Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes
Patients who present with type 2 diabetes and PAD often face substantial mobility issues. According to new data presented at ACC.25, however, treatment with semaglutide could represent a major step forward for this high-risk population.
FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths
One product is being pulled from the market, and the other is receiving updated instructions for use.
AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs
Researchers developed several new AI models that could guide the management of patients with non-valvular atrial fibrillation. There is still some work to do in terms of accuracy, but they already appear to outperform the traditional risk scores being used today.
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension
The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH.
Philips pulls endovascular devices from market after safety issues prompt Class I recall
Philips is recalling all sizes of its Tack Endovascular System after 20 patient injuries were reported. Interventional cardiologists are urged to stop using the device immediately.

A fresh look at managing patients with type B aortic dissection

The new guideline calls for a “stepwise approach," followed by close clinical surveillance, when treating uncomplicated TBAD. In some cases, however, earlier endovascular treatments may be necessary.

Tracking non-primary PCI outcomes among men and women

The study's authors believe this to be the largest analysis of its kind.

FDA announces recall of 95,000 directional atherectomy systems after 55 injuries

Significant issues have been reported with the catheter’s guidewire.

Watching too much TV linked to greater risk of cardiovascular issues

In case there was any doubt, streaming an entire season of a TV show in one sitting may not be good for your health.

Still No. 1: CABG outperforms FFR-PCI when treating CAD

The new analysis, published in the New England Journal of Medicine, represents the latest chapter in one of interventional cardiology’s largest ongoing debates.

3 months of anticoagulation therapy might be too long for young patients with provoked VTE

Three months of anticoagulation therapy is the go-to option when treating these younger patients—but it could be time for a change.

Meet the RNA molecule that guards against vascular disease

Researchers hope their work can help guide future treatments for atherosclerosis and other harmful diseases.

RAAS inhibitors help limit adverse outcomes among CAD patients

The study included data from more than 165,000 patients with coronary artery disease (CAD).

Vascular & Endovascular

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes

FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths

AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs

ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

Philips pulls endovascular devices from market after safety issues prompt Class I recall